Search

everythinglearnresearchcommunity

for

Search:↓

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Immune changes and specific genes contribute to male hair loss.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

New drug delivery systems improve treatment effectiveness and patient experience.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Interferon and ribavirin can cause serious skin reactions and other health issues.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Rodent models helped understand psoriasis but none perfectly replicated the disease.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Finasteride can cause a unique skin reaction on the penile shaft.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

COVID-19 vaccines have been linked to an increase in hair loss conditions.